Advanced Medical Solutions (GB:AMS) has released an update.
Advanced Medical Solutions Group, a global leader in tissue-healing technologies, is set to release its interim financial results for the first half of 2024 on September 18. The company, known for its innovative surgical products and wound care dressings, has expanded significantly through seven acquisitions since 2019. With a broad portfolio that includes brands like LiquiBand and RESORBA, AMS continues to grow, backed by its extensive R&D and a diverse global sales network.
For further insights into GB:AMS stock, check out TipRanks’ Stock Analysis page.
